We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories

149 hedge funds and large institutions have $862M invested in Dr. Reddy's Laboratories in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more call options, than puts

Call options by funds: $484K | Put options by funds: $363K

16% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 19

2% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 47

1% more funds holding

Funds holding: 148149 (+1)

0.32% less ownership

Funds ownership: 64.56%64.24% (-0.32%)

1% less capital invested

Capital invested by funds: $870M → $862M (-$8.3M)

Holders
149
Holders Change
+1
Holders Change %
+0.68%
% of All Funds
3.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
48
Reduced
47
Closed
19
Calls
$484K
Puts
$363K
Net Calls
+$121K
Net Calls Change
+$215K
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
26
Wells Fargo
California
$6.09M +$4.11M +493,230 +188%
O
27
Ossiam
France
$5.63M
SEI Investments
28
SEI Investments
Pennsylvania
$5.3M -$394K -47,275 -7%
First Trust Advisors
29
First Trust Advisors
Illinois
$4.96M +$488K +58,580 +11%
Sumitomo Mitsui Trust Group
30
Sumitomo Mitsui Trust Group
Japan
$4.66M
NVCHI
31
New Vernon Capital Holdings II
New Jersey
$4.31M +$1.99M +238,315 +81%
N
32
Nuveen
North Carolina
$4.09M -$1.06M -126,935 -20%
DZ Bank
33
DZ Bank
Germany
$3.93M
Man Group
34
Man Group
United Kingdom
$3.8M +$3.93M +470,880 New
PAM
35
Panagora Asset Management
Massachusetts
$3.57M -$994K -119,165 -21%
AI
36
Axiom Investors
Connecticut
$3.55M +$3.67M +440,350 New
Lazard Asset Management
37
Lazard Asset Management
New York
$3.25M +$717K +86,000 +27%
Prudential Financial
38
Prudential Financial
New Jersey
$3.1M -$121K -14,500 -4%
CAM
39
ClariVest Asset Management
California
$3.08M -$500K -60,000 -14%
DI
40
Dalton Investments
Nevada
$3.05M
Bank of Montreal
41
Bank of Montreal
Ontario, Canada
$2.96M -$3.95M -474,240 -56%
BNP Paribas Financial Markets
42
BNP Paribas Financial Markets
France
$2.79M -$89.8K -10,765 -3%
DWA
43
Dorsey Wright & Associates
California
$2.77M -$327K -39,220 -10%
Bank of New York Mellon
44
Bank of New York Mellon
New York
$2.75M +$2.42M +290,000 +566%
VI
45
Vestcor Inc
New Brunswick, Canada
$2.74M
Ninety One (UK)
46
Ninety One (UK)
United Kingdom
$2.64M +$2.73M +327,515 New
BIM
47
Bogle Investment Management
Massachusetts
$2.52M +$201K +24,085 +8%
Deutsche Bank
48
Deutsche Bank
Germany
$2.18M +$452K +54,180 +25%
UBS Group
49
UBS Group
Switzerland
$2.02M -$250K -29,935 -11%
CS
50
Credit Suisse
Switzerland
$1.9M -$828K -99,270 -30%

RDY Hedge Fund Activity: Q1 2020 in Review

149 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2020, worth a combined $862M — down 0.95% from $870M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new RDY positions and 19 closed out — a net gain of 3 holders — while 48 added to existing stakes and 47 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $12.8M. The largest seller was BlackRock, cutting an estimated $23.5M.

  • 149 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2020, up from 148 in Q4 2019.
  • Funds reported $862M of Dr. Reddy's Laboratories stock for Q1 2020, down 0.95% quarter-over-quarter.
  • 22 funds opened new Dr. Reddy's Laboratories positions in Q1 2020 and 19 closed out, a net change of +3 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q1 2020 was Goldman Sachs, an estimated $12.8M added.
  • The largest Dr. Reddy's Laboratories seller in Q1 2020 was BlackRock, an estimated $23.5M sold.

Based on aggregated 13F filings for Q1 2020.